DE60036536T2 - Verfahren zur diagnose von endometriose - Google Patents

Verfahren zur diagnose von endometriose Download PDF

Info

Publication number
DE60036536T2
DE60036536T2 DE60036536T DE60036536T DE60036536T2 DE 60036536 T2 DE60036536 T2 DE 60036536T2 DE 60036536 T DE60036536 T DE 60036536T DE 60036536 T DE60036536 T DE 60036536T DE 60036536 T2 DE60036536 T2 DE 60036536T2
Authority
DE
Germany
Prior art keywords
cd45ro
cd45ra
hladr
endometriosis
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60036536T
Other languages
German (de)
English (en)
Other versions
DE60036536D1 (de
Inventor
Danièle Montreal GAGNE
Diane Pointe Calumet GOSSELIN
Patrice Sainte Dorothee/Laval HUGO
Pierre Laval MIRON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Medical Solutions Diagnostics Inc USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Medical Solutions Diagnostics Inc USA filed Critical Siemens Medical Solutions Diagnostics Inc USA
Publication of DE60036536D1 publication Critical patent/DE60036536D1/de
Application granted granted Critical
Publication of DE60036536T2 publication Critical patent/DE60036536T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Devices That Are Associated With Refrigeration Equipment (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
DE60036536T 1999-01-25 2000-01-24 Verfahren zur diagnose von endometriose Expired - Lifetime DE60036536T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11703199P 1999-01-25 1999-01-25
US117031P 1999-01-25
PCT/CA2000/000060 WO2000043789A1 (en) 1999-01-25 2000-01-24 Method and diagnostic kit for diagnosis of endometriosis

Publications (2)

Publication Number Publication Date
DE60036536D1 DE60036536D1 (de) 2007-11-08
DE60036536T2 true DE60036536T2 (de) 2008-06-19

Family

ID=22370639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60036536T Expired - Lifetime DE60036536T2 (de) 1999-01-25 2000-01-24 Verfahren zur diagnose von endometriose

Country Status (10)

Country Link
EP (1) EP1147421B1 (enExample)
JP (1) JP2002535658A (enExample)
AT (1) ATE374370T1 (enExample)
AU (1) AU2088800A (enExample)
BR (1) BR0007702A (enExample)
CA (1) CA2359200A1 (enExample)
DE (1) DE60036536T2 (enExample)
ES (1) ES2292424T3 (enExample)
NZ (1) NZ513692A (enExample)
WO (1) WO2000043789A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003244815A1 (en) * 2002-02-13 2003-09-04 Metriogene Biosciences Inc. Cd16b as a marker for the diagnosis of endometriosis
US20050100967A1 (en) * 2003-07-11 2005-05-12 Science & Technology Corporation @ Unm Detection of endometrial pathology
US20060008876A1 (en) 2004-07-07 2006-01-12 Shami A S E ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
EP1931993A2 (en) * 2005-09-14 2008-06-18 Medizinische Universität Wien Means and methods for diagnosing endometriosis
WO2017039751A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Mutant peptides and methods of treating subjects using the same
EP3215847A4 (en) * 2014-11-03 2018-02-14 Bioincept LLC Pif binding as a marker for immune dysregulation
CA2996874A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Compositions and methods for the treatment of neurodamage
CN113994208A (zh) * 2019-04-26 2022-01-28 中外制药株式会社 子宫内膜异位症的诊断方法、疾病状态监测方法和试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03202769A (ja) * 1989-03-07 1991-09-04 Adeza Biomedical Corp 子宮内膜症診断の方法及び試薬
US5618680A (en) * 1994-12-28 1997-04-08 Institut De Medecine De La Reproduction De Montreal Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis
JP2001501300A (ja) * 1996-09-06 2001-01-30 オステオメーター・ビオテク・エー／エス ヒト子宮内膜の生化学的マーカー

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose

Also Published As

Publication number Publication date
ATE374370T1 (de) 2007-10-15
BR0007702A (pt) 2002-09-10
EP1147421A1 (en) 2001-10-24
WO2000043789A1 (en) 2000-07-27
EP1147421B1 (en) 2007-09-26
NZ513692A (en) 2001-09-28
CA2359200A1 (en) 2000-07-27
AU2088800A (en) 2000-08-07
JP2002535658A (ja) 2002-10-22
DE60036536D1 (de) 2007-11-08
ES2292424T3 (es) 2008-03-16

Similar Documents

Publication Publication Date Title
DE69433504T2 (de) ALPHAvBETA3 INTEGRIN ALS INDIKATOR FÜR ENDOMETRIOSE
Kolanska et al. Proportion of cytotoxic peripheral blood natural killer cells and T-cell large granular lymphocytes in recurrent miscarriage and repeated implantation failure: case–control study and meta-analysis
Gagné et al. Development of a nonsurgical diagnostic tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA-125 levels
Florian et al. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes
Garfield et al. Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus
DE60033380T2 (de) Verfahren zur quantifizierung der zahl von leukozyten in einer blutprobe
Kunnen et al. The effect of Porphyromonas gingivalis lipopolysaccharide on pregnancy in the rat
DE60036536T2 (de) Verfahren zur diagnose von endometriose
Perez et al. Meibomian gland dysfunction: a route of ocular graft-versus-host disease progression that drives a vicious cycle of ocular surface inflammatory damage
US6743595B1 (en) Method and diagnostic kit for diagnosis of endometriosis
Kuon et al. Pre-pregnancy levels of peripheral natural killer cells as markers for immunomodulatory treatment in patients with recurrent miscarriage
Jacques et al. Necrotizing funisitis: a study of 45 cases
DE69414871T2 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
WO2004003548A1 (de) Verfahren zur eigenschaftsbestimmung und/oder klassifikation von zirkulierenden macrophagen sowie analyseanordnung zur durchführung des verfahrens
US20030219835A1 (en) CD16b as a marker for the diagnosis of endometriosis
EP1179179B1 (de) Verwendung eines antikörpers zur detektion von basophilen und/oder mastzellen
Nanni-Costa et al. Flow cytometry evaluation of urinary sediment in renal transplantation
CN113832222A (zh) 生物标志物在制备用于诊断流产的试剂盒中的用途
DE69912453T2 (de) Verfahren und materialien zur diagnose instabiler angina
Blackwell et al. Unexplained fetal death is associated with changes in the adaptive limb of the maternal immune response consistent with prior antigenic exposure
CN112557283A (zh) 一组反复妊娠丢失疾病诊疗免疫标志物及应用
Sebire et al. Trophoblast proliferation is increased in chorionic villi from pregnancies with fetal trisomy 18
US20030148405A1 (en) Novel method of testing myelotoxicity with the use of flow cytometer
DE102004032253A1 (de) Vorrichtung zur intravaginalen Probenahme von Menstrualblut mit integriertem immunologischen Schnelltest zur Erkennung einer Endometriose
JP2007051980A (ja) 移植片対宿主病の検査方法、検査用試薬ならびに予防薬および／または治療薬のスクリーニング方法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC. (N.D.GES.D, US